Noveris Health Sciences is trading 10% up today at CA$1.10 in a technical rebound following a week of sharp declines and heavy volatility.
- The move follows a period of profit-taking in the speculative biotech name, with the stock recovering from recent lows.
- There are no new fundamental catalysts today; the price action aligns with a technical bounce following previously announced corporate updates and the recent AGM.